National Institutes of Health to Grant Exclusive Patent License for Cancer Treatment

Summary

The National Institutes of Health is considering granting an exclusive patent license to Lion Biotechnologies, Inc. to develop and use autologous tumor-infiltrating lymphocyte adoptive cells for treating metastatic melanoma, as outlined in patent applications.